指南与共识心力衰竭与心肌病心律失常

射血分数降低的心衰合并房颤患者出院时指南导向治疗与预后

Guideline-directed therapy at discharge in patients with heart failure and atrial fibrillation.
指南 / 共识 · Heart · 2019-09-06

基于韩国急性心衰注册研究5625例急性心衰患者中的986例合并房颤者,计算出院时ACEI/ARB、β受体阻滞剂、MRA和抗凝药的指南依从性评分。依从性越好,60天和1年死亡率及复合终点呈显著下降趋势;依从性差与60天死亡风险(HR 4.75)和1年死亡风险(HR 2.34)显著升高相关。

要点

  • 心衰合并房颤患者出院时指南依从性越好,60天和1年预后越佳。
  • 依从性差者60天死亡风险显著升高(HR 4.75;95%CI 1.77–12.74)。
  • 依从性差者1年死亡风险显著高于依从性好者(HR 2.34;95%CI 1.39–3.97)。

核心结论

  • 心衰合并房颤患者出院时对指南推荐治疗的依从性越好,60天和1年预后越好。

研究设计与样本

  • 基于韩国急性心衰注册研究5625例急性心衰患者,分析其中986例合并房颤者。
  • 计算出院时ACEI、ARB、β受体阻滞剂、MRA和抗凝药的指南依从性评分。

主要发现

  • 依从性越好,60天和1年死亡率及复合终点呈显著下降趋势。
  • 依从性差者60天死亡风险显著高于依从性好者(HR 4.75;95%CI 1.77–12.74)。
  • 依从性差者60天复合终点风险显著高于依从性好者(HR 2.36;95%CI 1.33–4.18)。
  • 依从性差者1年死亡风险显著高于依从性中等者(HR 1.64;95%CI 1.15–2.33)和依从性好者(HR 2.34;95%CI 1.39–3.97)。
  • 依从性差者1年复合终点风险显著高于依从性好者(HR 1.58;95%CI 1.07–2.33)。

关键数值与推荐

  • 指南依从性评分基于出院时ACEI、ARB、β受体阻滞剂、MRA和抗凝药的处方计算。
  • 依从性差者60天死亡HR 4.75(95%CI 1.77–12.74),1年死亡HR 2.34(95%CI 1.39–3.97)。

临床怎么用

  • 对心衰合并房颤患者,出院时应评估并优化ACEI/ARB、β受体阻滞剂、MRA和抗凝药的指南导向处方。
  • 出院时指南依从性可作为识别60天和1年高死亡风险患者的参考指标。

局限性

  • 原文未报告局限性内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: This study evaluated the relationship between guideline adherence for recommended therapy on discharge and relevant 60-day and 1-year clinical outcomes in patients with acute heart failure (HF) with reduced ejection fraction and atrial fibrillation (AF). METHODS: Of 5625 acute patients with HF in the Korean Acute Heart Failure registry, 986 patients with HF and documented AF were analysed. Guideline adherence scores were calculated for the prescription of ACE inhibitors, angiotensin receptor blockers, β-blockers, mineralocorticoid receptor antagonists and anticoagulants. RESULTS: In patients with HF with AF, there was a significant trend of reduced 60-day and 1-year mortality rates and the composite end point with guideline adherence. According to the Cox proportion hazard model, poor adherence was associated with a significantly higher risk of 60-day mortality (HR 4.75; 95% CI 1.77 to 12.74) and the composite end point (HR 2.36; 95% CI 1.33 to 4.18) compared with good adherence. Furthermore, poor adherence was associated with a significantly higher risk of 1-year mortality compared with moderate (HR 1.64; 95% CI 1.15 to 2.33) and good adherence (HR 2.34; 95% CI 1.39 to 3.97) and with a higher risk of the 1-year composite end point compared with good adherence (HR 1.58; 95% CI 1.07 to 2.33). CONCLUSION: Better adherence to guidelines was associated with better 60-day and 1-year prognoses in patients with HF with AF.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Ahn MS, Yoo BS, Yoon J, et al. Guideline-directed therapy at discharge in patients with heart failure and atrial fibrillation. Heart. 2019. PMID: 31492703. doi:10.1136/heartjnl-2019-315240

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。